Substance-induced psychosis vs primary psychosis (differentiation)
Substance psychosis · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Distinguishing a substance-induced psychotic disorder from a primary psychotic illness guides prognosis and management. Substance-induced psychosis typically resolves with abstinence over days to weeks, but a substantial proportion (especially with cannabis/stimulants) later convert to a primary psychotic disorder, so follow-up is essential.
Red flags
- Fever, reduced consciousness or focal signs (encephalitis/organic)
- Persisting psychosis despite abstinence (suggests primary disorder)
- Command hallucinations or high-risk behaviour
- Suicidal or homicidal ideation
- First presentation at an atypical age
Assessment
Differential diagnosis
- Substance-induced psychosis (temporal link, resolves with abstinence)
- First-episode primary psychosis (schizophrenia spectrum)
- Acute mania with psychotic features
- Organic delirium or encephalitis (exclude)
- Drug intoxication/withdrawal state
Investigations
- Toxicology screen (note NPS/synthetic cannabinoids not detected) and alcohol level
- Capillary glucose, observations and organic screen
- Bloods: FBC, U&E, LFTs, CRP, calcium, TFTs
- ECG before antipsychotics
- CT head / LP if encephalitis or organic cause suspected (atypical features, fever, reduced consciousness)
Management
- Establish temporal relationship between substance use and psychotic symptoms
- Exclude organic causes and intoxication/withdrawal states
- Provide a safe, low-stimulus environment and de-escalate
- Manage acute agitation with benzodiazepines; use antipsychotics judiciously
- Observe for resolution with abstinence (supports substance-induced diagnosis)
- Avoid committing to a diagnosis of schizophrenia at first presentation
- Refer to psychiatry/early intervention in psychosis and arrange follow-up
- Advise on abstinence and refer to substance-misuse services
Drugs & doses
Lorazepam — 1-2 mg PO/IM for agitation, repeat; max 4 mg/24h caution
Haloperidol — 5 mg IM (2.5 mg elderly) with ECG, after benzodiazepine, for severe psychosis
Olanzapine — 10 mg IM (5 mg elderly), not within 1 h of parenteral benzodiazepine
Oral antipsychotic (e.g. olanzapine/risperidone) continued short-term with psychiatric follow-up
Disposition
Admit or arrange urgent psychiatric assessment (MHA if risk and refusing care) for acute psychosis; refer to early intervention in psychosis and substance-misuse services, and ensure follow-up to detect conversion to a primary disorder.
Complications & pitfalls
- Conversion to a primary psychotic disorder
- Self-harm or harm to others during the acute episode
- Missed organic cause (encephalitis)
- Antipsychotic side-effects (dystonia, QT, NMS)
- Disengagement and relapse
Exam pearls
- A clear temporal link to the substance and resolution with abstinence supports substance-induced psychosis
- A significant minority (notably cannabis/stimulant-related) convert to schizophrenia — follow-up is essential
- Synthetic cannabinoids and NPS are not detected on routine screens — diagnosis is clinical
- Do not label a first episode as schizophrenia — refer to early intervention services
- Persisting symptoms beyond a month of abstinence point away from a purely substance-induced cause
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.